GlassScriptPhysician profile
Melissa Shah
NPI 1144474511
$4,191.51
in general payments reported to CMS, 2019-2025
12 companies · $847 in 2025
The $847 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $152 · 2021: $362 · 2022: $1,257 · 2023: $405 · 2024: $598 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,298.39 | 2021-2025 | Abre, In.Pact Av, Endurant Iis |
| Medtronic Vascular, INC. | $568.10 | 2019-2020 | |
| Boston Scientific Corporation | $304.08 | 2019-2024 | Eluvia |
| W. L. Gore & Associates, INC. | $254.76 | 2022-2024 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Inari Medical, INC. | $162.85 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lemaitre Vascular, INC. | $153.78 | 2022-2023 | Hydro Lemaitre Valvulotome |
| Stryker Corporation | $150.66 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acacia Pharma INC | $125.04 | 2021 | |
| Cagent Vascular INC | $72.25 | 2024 | Serrantor |
| Bard Peripheral Vascular, INC. | $63.75 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $24.42 | 2020 | |
| Integra Lifesciences Corporation | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.